Skip to main content
Equibles

FMR LLC

Position in MYGN — Myriad Genetics Inc

CIK 315066 BOSTON, MA
Back to MYGN Full portfolio

Position in MYGN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$4,409,358
+$1,775,613 QoQ
Shares Held
772,217
+31.9% QoQ
Ownership
0.807%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 196 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MYGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

FMR LLC holds $20,923,751,494 across 34 Diagnostics & Research names. MYGN ranks #22 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 14,084,488 $7,061,398,899
2 DHR
Danaher Corp /De/
 29,540,895 $5,626,949,677
3 NTRA
Natera, Inc.
 5,451,396 $1,479,781,442
4 CRL
Charles River Laboratories International, Inc.
 4,239,752 $961,533,354
5 ICLR
Icon PLC
 5,271,321 $915,681,168
6 GH
Guardant Health, Inc.
 5,488,272 $823,405,446
7 ILMN
Illumina, Inc.
 4,523,417 $795,352,409
8 A
Agilent Technologies, Inc.
 5,076,167 $674,267,260

All Filings in MYGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,409,358 772,217
2026-03-31 $2,633,745 585,277
2025-12-31 $3,019,310 490,945
2025-09-30 $2,879,165 398,225
2025-06-30 $1,851,665 348,713
2025-03-31 $1,531,413 172,651
2024-12-31 $1,438,082 104,893
2024-09-30 $1,912,423 69,822
2024-06-30 $1,382,063 56,503
2024-03-31 $336,855 15,800
2023-12-31 $291,750 15,243
2023-09-30 $247,560 15,434
2023-06-30 $356,252 15,369
2023-03-31 $364,478 15,690
2022-12-31 $93,400 6,437
2022-09-30 $322,623 16,909
2022-06-30 $302,439 16,645
2022-03-31 $422,552 16,768
2021-12-31 $14,406 522
2021-09-30 $16,854 522
2021-06-30 $2,018 66
2021-03-31 $60 2
2020-12-31 $8,639 437
2020-09-30 $5,528 424
2020-06-30 $9,434 832
2020-03-31 $2,786,042 194,692